Wagner Wealth Management (South Carolina)’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-29
Closed -$1K 729
2018
Q1
$1K Buy
+29
New +$569 ﹤0.01% 621
2017
Q4
Hold
0
796

Wagner Wealth Management (South Carolina)'s IPXL Position: Q2 2018 in Review

Wagner Wealth Management (South Carolina) sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 29 shares — an estimated $1K sold.

Wagner Wealth Management (South Carolina) first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Wagner Wealth Management (South Carolina) reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 29 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
  • Wagner Wealth Management (South Carolina) first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q2 2018, filed 1 Aug 2018.